Episode 1- Mobilisation in the ICU

 September 16

by Jonathan Downham

Summary
For much of critical care history, immobility was the norm: patients were sedated, kept still, and “protected.” But decades of research have revealed the hidden costs — profound muscle wasting, delirium, and long-term disability.

Jonathan explores how our understanding of mobilisation in ICU has evolved — from the recognition of harm caused by bedrest, to the first landmark studies proving that early movement is both feasible and beneficial.

From Bedrest to Better: Why Mobilise in ICU?

  • ICU-acquired weakness: Patients can lose 15–20% of muscle mass within the first week of critical illness.

  • Long-term outcomes: ARDS survivors tracked for five years showed persistent disability and reduced independence.

  • Sedation & delirium: Deep sedation increases delirium risk; mobilisation reduces both incidence and duration.

  • Physiological rationale: Even minimal movement supports cardiovascular tone, respiratory function, circulation, and cognition.

  • Core message: Bedrest is not neutral — it is actively harmful. Mobilisation offers protection for both brain and body.

Proof in Practice: The First Mobilisation Trials

  • Feasibility (Morris et al., 2008): Protocol-led mobilisation cut time to first mobilisation (5 vs 11 days), with no increase in adverse events.

  • Landmark RCT (Schweickert et al., 2009):

    • Early PT/OT + daily sedation interruption vs SAT alone.

    • 59% vs 35% regained independence at discharge.

    • Patients had less delirium and spent fewer days ventilated.

  • Implementation (Needham et al.): Demonstrated how embedding mobilisation into daily ICU practice improves outcomes and serves as a model for quality improvement.

  • Core message: Early mobilisation is not only possible — it improves patient-centred outcomes safely.

Key Takeaways 

  • Bedrest and heavy sedation accelerate weakness, delirium, and disability.

  • Mobilisation is both biologically plausible and clinically effective.

  • Early trials proved feasibility, safety, and functional benefits.

  • Success requires:

    • Lighter sedation targets and daily SATs.

    • Interdisciplinary teamwork (nursing, PT/OT, medical).

    • Structured protocols and safety screens.

Overall message: Mobilisation should no longer be an afterthought in ICU. It is a therapeutic intervention — one that supports recovery, preserves dignity, and helps patients walk out of intensive care with more than just survival.

share this

Related Posts

Decompensated Alcohol Related Liver Disease Part 2

We return to our 48-year-old patient: jaundiced, hypotensive, drowsy, and bleeding. In decompensated cirrhosis, every treatment targets a disrupted system — splanchnic vasodilation, portal hypertension, toxin accumulation, and renal hypoperfusion.Although these patients look fluid overloaded, they are effectively hypovolaemic. Start with small aliquots of balanced crystalloid, avoiding 0.9% saline. In hepatorenal syndrome or tense ascites, 20% albumin is

Read More

Decompensated Alcohol Related Liver Disease

In this episode, I walk through the real-world critical care management of acute decompensated alcohol-related liver disease, using a high-risk ICU case to anchor the discussion. The focus is on understanding the underlying physiology—portal hypertension, rebalanced haemostasis, hepatic encephalopathy, infection, and hepatorenal syndrome—and translating that physiology into clear first-hour priorities at the bedside.  Listeners are

Read More